IBDEI0QZ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13276,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13276,1,4,0)
 ;;=4^157.9
 ;;^UTILITY(U,$J,358.3,13276,1,5,0)
 ;;=5^Pancreas CA, NOS
 ;;^UTILITY(U,$J,358.3,13276,2)
 ;;=^267103
 ;;^UTILITY(U,$J,358.3,13277,0)
 ;;=185.^^81^832^14
 ;;^UTILITY(U,$J,358.3,13277,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13277,1,4,0)
 ;;=4^185.
 ;;^UTILITY(U,$J,358.3,13277,1,5,0)
 ;;=5^Prostate CA
 ;;^UTILITY(U,$J,358.3,13277,2)
 ;;=^99481
 ;;^UTILITY(U,$J,358.3,13278,0)
 ;;=112.1^^81^833^2
 ;;^UTILITY(U,$J,358.3,13278,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13278,1,4,0)
 ;;=4^112.1
 ;;^UTILITY(U,$J,358.3,13278,1,5,0)
 ;;=5^Candidal Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,13278,2)
 ;;=^18615
 ;;^UTILITY(U,$J,358.3,13279,0)
 ;;=363.20^^81^833^3
 ;;^UTILITY(U,$J,358.3,13279,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13279,1,4,0)
 ;;=4^363.20
 ;;^UTILITY(U,$J,358.3,13279,1,5,0)
 ;;=5^Chorioretinitis NOS
 ;;^UTILITY(U,$J,358.3,13279,2)
 ;;=^23913
 ;;^UTILITY(U,$J,358.3,13280,0)
 ;;=321.0^^81^833^4
 ;;^UTILITY(U,$J,358.3,13280,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13280,1,4,0)
 ;;=4^321.0
 ;;^UTILITY(U,$J,358.3,13280,1,5,0)
 ;;=5^Cryptococcal Meningitis
 ;;^UTILITY(U,$J,358.3,13280,2)
 ;;=^186200
 ;;^UTILITY(U,$J,358.3,13281,0)
 ;;=117.5^^81^833^5
 ;;^UTILITY(U,$J,358.3,13281,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13281,1,4,0)
 ;;=4^117.5
 ;;^UTILITY(U,$J,358.3,13281,1,5,0)
 ;;=5^Cryptococcosis
 ;;^UTILITY(U,$J,358.3,13281,2)
 ;;=^29608
 ;;^UTILITY(U,$J,358.3,13282,0)
 ;;=288.02^^81^833^6
 ;;^UTILITY(U,$J,358.3,13282,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13282,1,4,0)
 ;;=4^288.02
 ;;^UTILITY(U,$J,358.3,13282,1,5,0)
 ;;=5^Cyclic Neutropenia
 ;;^UTILITY(U,$J,358.3,13282,2)
 ;;=^334039
 ;;^UTILITY(U,$J,358.3,13283,0)
 ;;=078.5^^81^833^7
 ;;^UTILITY(U,$J,358.3,13283,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13283,1,4,0)
 ;;=4^078.5
 ;;^UTILITY(U,$J,358.3,13283,1,5,0)
 ;;=5^Cytomegaloviral Disease
 ;;^UTILITY(U,$J,358.3,13283,2)
 ;;=^30676
 ;;^UTILITY(U,$J,358.3,13284,0)
 ;;=110.5^^81^833^8
 ;;^UTILITY(U,$J,358.3,13284,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13284,1,4,0)
 ;;=4^110.5
 ;;^UTILITY(U,$J,358.3,13284,1,5,0)
 ;;=5^Dermatophytosis of Body
 ;;^UTILITY(U,$J,358.3,13284,2)
 ;;=^33179
 ;;^UTILITY(U,$J,358.3,13285,0)
 ;;=110.4^^81^833^9
 ;;^UTILITY(U,$J,358.3,13285,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13285,1,4,0)
 ;;=4^110.4
 ;;^UTILITY(U,$J,358.3,13285,1,5,0)
 ;;=5^Dermatophytosis of Foot
 ;;^UTILITY(U,$J,358.3,13285,2)
 ;;=^33168
 ;;^UTILITY(U,$J,358.3,13286,0)
 ;;=288.03^^81^833^10
 ;;^UTILITY(U,$J,358.3,13286,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13286,1,4,0)
 ;;=4^288.03
 ;;^UTILITY(U,$J,358.3,13286,1,5,0)
 ;;=5^Drug Induced Neutropenia
 ;;^UTILITY(U,$J,358.3,13286,2)
 ;;=^334040
 ;;^UTILITY(U,$J,358.3,13287,0)
 ;;=054.10^^81^833^11
 ;;^UTILITY(U,$J,358.3,13287,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13287,1,4,0)
 ;;=4^054.10
 ;;^UTILITY(U,$J,358.3,13287,1,5,0)
 ;;=5^Genital Herpes
 ;;^UTILITY(U,$J,358.3,13287,2)
 ;;=^56853
 ;;^UTILITY(U,$J,358.3,13288,0)
 ;;=070.51^^81^833^14
 ;;^UTILITY(U,$J,358.3,13288,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13288,1,4,0)
 ;;=4^070.51
 ;;^UTILITY(U,$J,358.3,13288,1,5,0)
 ;;=5^Hepatitis C w/o Coma
 ;;^UTILITY(U,$J,358.3,13288,2)
 ;;=^331778
 ;;^UTILITY(U,$J,358.3,13289,0)
 ;;=053.9^^81^833^15
 ;;^UTILITY(U,$J,358.3,13289,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13289,1,4,0)
 ;;=4^053.9
 ;;^UTILITY(U,$J,358.3,13289,1,5,0)
 ;;=5^Herpes Zoster NOS
 ;;^UTILITY(U,$J,358.3,13289,2)
 ;;=^56946
 ;;^UTILITY(U,$J,358.3,13290,0)
 ;;=042.^^81^833^12
